Loading clinical trials...
Loading clinical trials...
Efficacy of Roflumilast on Exacerbations in Patients With Non-cystic Fibrosis Bronchiectasis: a Randomized Double-blind Placebo-controlled Trial
Roflumilast compare with placebo for decrease infected exacerbation in non-cystic Bronchiectasis
Efficacy and RCT compare roflumilast vs placebo for 6 months in frequent infectious exacerbation in non-cystic bronchiectasis in Thailand
Age
18 - 80 years
Sex
ALL
Healthy Volunteers
No
Songklanagarind hospital
Songkhla, Thailand
Start Date
January 1, 2015
Primary Completion Date
December 1, 2015
Completion Date
December 1, 2015
Last Updated
October 10, 2019
40
ACTUAL participants
Roflumilast
DRUG
Placebo
DRUG
Lead Sponsor
Prince of Songkla University
NCT06166056
NCT02779478
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT07274631